Eagle Asset Management Inc Bio Rad Laboratories, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$304.11 - $351.99 $15,205 - $17,599	-50 Reduced 1.68%	2,927 $1.01 Million
Q4 2023 Feb 12, 2024	BUY	$269.37 - $365.04 $2,693 - $3,650	10 Added 0.34%	2,977 $961,000
Q3 2023 Nov 13, 2023	SELL	$350.25 - $422.63 $76,004 - $91,710	-217 Reduced 6.82%	2,967 $1.06 Million
Q2 2023 Aug 09, 2023	SELL	$359.49 - $486.4 $34,511 - $46,694	-96 Reduced 2.93%	3,184 $1.21 Million
Q1 2023 May 08, 2023	BUY	$418.69 - $503.0 $441,717 - $530,665	1,055 Added 47.42%	3,280 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $8,089 - $10,488	23 Added 1.04%	2,225 $935,000
Q3 2022 Nov 07, 2022	BUY	$412.59 - $563.26 $16,503 - $22,530	40 Added 1.85%	2,202 $918,000
Q2 2022 Aug 10, 2022	SELL	$463.67 - $597.16 $49,149 - $63,298	-106 Reduced 4.67%	2,162 $1.07 Million
Q1 2022 May 12, 2022	SELL	$524.57 - $735.42 $362,477 - $508,175	-691 Reduced 23.35%	2,268 $1.28 Million
Q4 2021 Feb 11, 2022	SELL	$708.84 - $794.68 $77,263 - $86,620	-109 Reduced 3.55%	2,959 $2.24 Million
Q3 2021 Nov 10, 2021	SELL	$657.71 - $825.77 $263,084 - $330,308	-400 Reduced 11.53%	3,068 $2.29 Million
Q2 2021 Aug 11, 2021	SELL	$576.64 - $649.04 $104,371 - $117,476	-181 Reduced 4.96%	3,468 $2.23 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $284,445 - $344,422	520 Added 16.62%	3,649 $2.12 Million
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $327,856 - $413,094	-642 Reduced 17.02%	3,129 $1.82 Million
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $702,094 - $827,502	-1,545 Reduced 29.06%	3,771 $1.94 Million
Q2 2020 Aug 12, 2020	SELL	$334.87 - $493.06 $1.21 Million - $1.78 Million	-3,611 Reduced 40.45%	5,316 $2.3 Million
Q1 2020 May 11, 2020	BUY	$320.01 - $409.07 $88,642 - $113,312	277 Added 3.2%	8,927 $3.13 Million
Q4 2019 Feb 07, 2020	SELL	$319.73 - $374.2 $139,082 - $162,777	-435 Reduced 4.79%	8,650 $3.2 Million
Q3 2019 Nov 04, 2019	SELL	$304.55 - $345.24 $621,586 - $704,634	-2,041 Reduced 18.34%	9,085 $3.02 Million
Q2 2019 Aug 05, 2019	SELL	$286.93 - $312.59 $804,551 - $876,502	-2,804 Reduced 20.13%	11,126 $3.48 Million
Q1 2019 May 01, 2019	SELL	$224.3 - $317.41 $55,402 - $78,400	-247 Reduced 1.74%	13,930 $4.26 Million
Q4 2018 Feb 11, 2019	BUY	$220.1 - $309.0 $1.57 Million - $2.2 Million	7,132 Added 101.23%	14,177 $3.29 Million
Q3 2018 Nov 08, 2018	SELL	$289.28 - $326.15 $1.14 Million - $1.29 Million	-3,942 Reduced 35.88%	7,045 $2.21 Million
Q2 2018 Aug 07, 2018	SELL	$244.1 - $303.88 $4.37 Million - $5.44 Million	-17,913 Reduced 61.98%	10,987 $3.17 Million
Q1 2018 May 09, 2018	SELL	$233.97 - $274.11 $2.86 Million - $3.35 Million	-12,210 Reduced 29.7%	28,900 $7.23 Million
Q4 2017 Feb 09, 2018	BUY	$216.94 - $271.3 $454,706 - $568,644	2,096 Added 5.37%	41,110 $9.86 Million
Q3 2017 Nov 09, 2017	BUY	$212.27 - $242.28 $8.28 Million - $9.45 Million	39,014	39,014 $8.69 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.37B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account